# FZATA, INC.: Development of a Dual-Action Oral Immunotherapy for Clostridioides difficile Prevention

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | FZATA, INC. |
| Location | HALETHORPE, MD |
| Project | Development of a Dual-Action Oral Immunotherapy for Clostridioides difficile Prevention |
| Project number | 1R44AI197301-01 |
| Mechanism | R44 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $313,095 |
| Awarded | 2026-09-11 |
| Project period | 2026-09-11 to 2027-02-28 |
| UEI | SLGDVHJS1Y85 |

## Why this score
- Award of $313,095.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11312101). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.